Loss of NF2/Merlin expression in advanced sporadic colorectal cancer

Cellular Oncology

Volumn 37, Issue 1, 2014, Pages 69-77

  Čačev, Tamara ^a   Aralica, Gorana ^b   Lončar, Božo ^b   Kapitanović, Sanja ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b University of Zagreb   (Croatia)

Author keywords

Colorectal cancer; Immunohistochemistry; LOH; Merlin; mRNA expression; NF2; NF2 isoform I and II; Western blot

Indexed keywords

AGED; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; NEOPLASM STAGING; NEUROFIBROMIN 2; PHOSPHORYLATION; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84894454267     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-013-0164-2     Document Type: Article

References (36)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics. CA Cancer J. Clin. 61, 69-90 (2011)
2. E.R. Fearon, Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 6, 479-507 (2011)
3. J.A. Trofatter, M.M. MacCollin, J.L. Rutter, J.R. Murrell, M.P. Duyao, D.M. Parry, R. Eldridge, N. Kley, A.G. Menon, K. Pulaski, A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72, 791-800 (1993) (Pubitemid 23093886)
4. T. Okada, L. You, F.G. Giancotti, Shedding light on Merlin's wizardry. Trends Cell Biol. 17, 222-229 (2007) (Pubitemid 46679247)
5. Z.S. Morris, A.I. McClatchey, Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling signaling in a mouse model of renal carcinoma. Proc. Natl. Acad. Sci. 106, 9767-9772 (2009)
6. H. Yu, Y. Zhang, L. Ye, W.G. Jiang, The FERM family proteins in cancer invasion and metastasis. Front. Biosci. 16, 1536-1550 (2011)
7. I. Stamenkovic, Q. Yu, Merlin, a magic linker between the extracellular cues and intracelular signaling pathways that regulate cell motility, proliferation and survival. Curr. Protein Pept. Sci. 11, 471-484 (2010)
8. A.B. Bianchi, T. Hara, V. Ramesh, J. Gao, A.J. Klein-Szanto, F. Morin, A.G. Menon, J.A. Trofatter, J.F. Gusella, B.R. Seizinger, N. Kley, Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat. Genet. 6, 185-192 (1994) (Pubitemid 24188601)
9. L. Sherman, H.M. Xu, R.T. Geist, S. Saporito-Irwin, N. Howells, H. Ponta, P. Herrlich, D.H. Gutmann, Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene 15, 2505-2509 (1997) (Pubitemid 27503537)
10. D.H. Gutmann, C.A. Haipek, L.K. Hoang, Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations. J. Neurosci. Res. 58, 706-716 (1999)
11. G.H. Xiao, A. Beeser, J. Chernoff, J.R. Testa, p21-activated kinase links Rac/Cdc42 signaling to merlin. J. Biol. Chem. 277, 883-886 (2002) (Pubitemid 34968830)
12. K. Alfthan, L. Heiska, M. Gronholm, G.H. Renkema, O. Carpen, Cyclic AMP dependent protein kinase phosphorylates Merlin at serine 518 independently of p21-activated kinase and promotes Merlin-Ezrin heterodimerization. J. Biol. Chem. 279, 1859-1866 (2004) (Pubitemid 38623276)
13. A.I. McClatchey, Merlin and ERM proteins: unappreciated roles in cancer development? Nat. Rev. Cancer 3, 877-884 (2003)
14. R.J. Shaw, A.I. McClatchey, T. Jacks, Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli. J. Biol. Chem. 273, 7757-7764 (1998) (Pubitemid 28152808)
15. R.J. Shaw, J.G. Paez, M. Curto, A. Yaktine, W.M. Pruitt, I. Saotome, J. O'Bryan, V. Gupta, N. Ratner, C.J. Der, T. Jacks, A.I. McClatchey, The NF2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev. Cell 1, 63-72 (2001) (Pubitemid 33586069)
16. T. Okada, M. Lopez-Lago, F.G. Giancotti, Merlin/NF2 mediates contact inhibition of growh by suppressing recruitment of Rac to the plasma membrane. J. Cell Biol. 171, 361-371 (2005) (Pubitemid 41540027)
17. D. Lallemand, J. Manent, A. Couvelard, A. Watilliaux, M. Siena, F. Chareyre, A. Lampin, M. Niwa-Kawakita, M. Kalamarides, M. Giovannini, Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas. Oncogene 28, 854-865 (2009)
18. M. Curto, A.I. McClatchey, Nf2/Merlin: A coordinator of receptor signalling and intercellular contact. Br. J. Cancer 98, 256-262 (2008) (Pubitemid 351161230)
19. M. Curto, B.K. Cole, D. Lallemand, C.H. Liu, A.I. McClatchey, Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J. Cell Biol. 177, 893-903 (2007) (Pubitemid 46873094)
20. A.I. McClatchey, R.G. Fehon, Merlin and the ERM proteins: regulators of receptor distribution and signaling at the cell cortex. Trends Cell Biol. 19, 198-206 (2009)
21. E.E. Bosco, Y. Nakai, E.F. Hennigan, N. Ratner, Y. Zheng, NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation. Oncogene 29, 2540-2549 (2010)
22. L. Zhou, E. Ercolano, S. Ammoun, M.C. Schmid, M.A. Barczyk, C.O. Hanemann, Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt/β-Catenin signaling linked to the PDGFR/Src and Rac/PAK pathways. Neoplasia 13, 1101-1112 (2011)
23. R. Spaventi, L. Pecur, K. Pavelic, Z.P. Pavelic, S. Spaventi, P.J. Stambrook, Human tumour bank in Croatia: a possible model for a small bank as a part of future European tumour bank network. Eur. J. Cancer 30A, 419 (1994) (Pubitemid 24152494)
24. P. Legoix, M.-F. Legrand, E. Ollagnon, G. Lenoir, G. Thomas, J. Zucman-Rossi, Characterisation of 16 polymorphic markers in the NF2 gene: application to hemizygosity detection. Hum. Mutat. 13, 290-293 (1999) (Pubitemid 29307073)
25. T. Cacev, S. Radosevic, R. Spaventi, K. Pavelic, S. Kapitanovic, NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut 54, 1129-1135 (2005) (Pubitemid 41025908)
26. D. Hanahan, R.A. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011)
27. A.I. McClatchey, I. Saotome, K. Mercer, D. Crowley, J.F. Gusella, R.T. Bronson, T. Jacks, Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev. 12, 1121-1133 (1998) (Pubitemid 28194048)
28. Y.K. Lau, L.B. Murray, S.S. Houshmandi, Y. Xu, D.H. Gutmann, Q. Yu, Merlin is a potent inhibitor of glioma growth. Cancer Res. 68, 5733-5742 (2008)
29. G.A. Rouleau, P. Merel, M. Lutchman, M. Sanson, J. Zucman, C. Marineau, K. Hoang-Xuan, S. Demczuk, C. Desmaze, B. Plougastel, Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363, 515-521 (1993) (Pubitemid 23186636)
30. A.K. Rustgi, L. Xu, D. Pinney, C. Sterner, R. Beauchamp, S. Schmidt, J.F. Gusella, V. Ramesh, Neurofibromatosis 2 gene in human colorectal cancer. Cancer Genet. Cytogenet. 84, 24-26 (1995)
31. C.Z. Zhou, Z.H. Peng, F. Zhang, G.Q. Qiu, L. He, Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma. World J. Gastroenterol. 8, 668-673 (2000)
32. D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell 100, 57-70 (2000) (Pubitemid 30046295)
33. K. Miura, W. Fujibuchi, I. Sasaki, Alternative pre-mRNA splicing in digestive tract malignancy. Cancer Sci. 102, 309-316 (2011)
34. H. Arakawa, N. Hayashi, H. Nagase, M. Ogawa, Y. Nakamura, Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum. Mol. Genet. 3, 565-568 (1994) (Pubitemid 24122167)
35. T. Sugai, W. Habano, S. Nakamura, N. Uesugi, S. Sasou, C. Itoh, A unique method for mutation analysis of tumor suppressor genes in colorectal carcinomas using a crypt isolation technique. Arch. Pathol. Lab. Med. 124, 382-386 (2000) (Pubitemid 30152139)
36. N.J. Yoo, S.W. Park, S.H. Lee, Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias. Pathology 44, 29-32 (2012)